Becoming 'indispensable': Developing innovative community pharmacy practices

Journal of the American Pharmacists Association

Volumn 45, Issue 3, 2005, Pages 376-389

  Willink, David P ^a   Isetts, Brian J ^b  

^a Village Pharmacy   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Collaborative practice; Community and ambulatory pharmacy; Medicare; Pharmaceutical care

Indexed keywords

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; INTERVIEW; MEDICAL PRACTICE; MEDICARE; PATIENT CARE; PHARMACEUTICAL CARE; PHARMACIST; PHARMACY; PHYSICIAN; COMPUTER SYSTEM; ECONOMICS; FINANCIAL MANAGEMENT; HEALTH PERSONNEL ATTITUDE; METHODOLOGY; ORGANIZATION AND MANAGEMENT; REVIEW;

ATTITUDE OF HEALTH PERSONNEL; COMMUNITY PHARMACY SERVICES; COMPUTER SYSTEMS; HUMANS; INTERVIEWS; MARKETING OF HEALTH SERVICES;

EID: 22144480657     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/1544345054003859     Document Type: Article

References (50)

1. Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in Project Impact: Hyperlipidemia. J Am Pharm Assoc. 2000;40:157-73.
2. Cranor CW, Christensen DB. The Asheville project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:149-59.
3. Isetts BJ, Brown LM, Schondelmeyer SW, Lenarz I.A. Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic goals. Arch Intern Med. 2003;163:1813-20.
4. Tsuyuki RT, Johnson JA, Teo KK, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management. The Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med. 2002;162:1149-55.
5. Erickson SR, Slaughter MS, Halapy H. Pharmacists' ability to influence outcomes of hypertension therapy. Pharmacotherapy. 1997;17:140-7.
6. Shibley MC, Pugh CB. Implementation of pharmaceutical care services for patients with dyslipidemias by independent community pharmacy practitioners. Ann Pharmacother. 1997;31:713-9.
7. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice: the clinician's guide, 2nd ed., New York: McGraw-Hill; 2004.
8. Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes. Cochrane Database Syst Rev. 2000;(3):CD000336. Review.
9. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282:267-70.
10. Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003;163:2014-8.
11. Chiquette E, Amoato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med. 1998;158:1641-7.
12. Kaushal R, Bates DW. The clinical pharmacist's role in preventing adverse drug events. In: Shojania K, Duncan B, McDonald K, Wachter RM, eds. Making health care safer: a critical analysis of patient safety practices. Rockville, Md.: Agency for Healthcare Research and Quality; 2001:chapt 7. Evidence Report/Technology Assessment No. 43; AHRQ publication 01-E058.
13. Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the pharmacist in heart failure assessment recommendation and monitoring (PHARM) study. Arch Intern Med. 1999;159:1939-45.
14. Cranor CW, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:173-84.
15. Schumock GT, Butler MG, Meek PD, et al. Evidence of the economic benefit of clinical pharmacy services-1996-2000. Pharmacotherapy. 2003;23:113-32.
16. Johnson JA, Bootman JL. Drug-related morbidity and mortality and the economic impact of pharmaceutical care. Am J Health Syst Pharm. 1997;54:554-8.
17. Schumock GT, Meek PD, Ploetz PA, Vermeulen LC. Economic evaluation of clinical pharmacy service-1988-1995. Pharmacotherapy. 1996;16:1188-208.
18. Hatoum HT, Akhras K. 1993 Bibliography: a 32-year literature review on the value and acceptance of ambulatory care provided by pharmacists. Ann Pharmacother. 1993;27:1106-19.
19. Hatoum HT, Catizone C, Hutchinson RA, Purohit A. Eleven year review of the pharmacy literature: documentation of the value and acceptance of clinical pharmacy. Drug Intell Clin Pharm. 1986;20:33-48.
20. Koch KE. Trends in collaborative drug therapy management. Drug Benefit Trends. 2000;12(1):45-54.
21. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc. 2001;41:192-9.
22. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice. New York: McGraw-Hill; 1998.
23. Carter BL, Malone DC, Billups SJ, et al. Interpreting the findings of the IMPROVE study. Am J Health Syst Pharm. 2001;58:1330-7.
24. Cording MA, Engelbrecht-Zadvorny EB, Pettit BJ, et al. Development of a pharmacist-managed lipid clinic. Ann Pharmacother. 2002;36:892-904.
25. Cranor CW, Christensen DB. The Asheville Project: factors associated with outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:160-72.
26. McDonough RP, Doucette WR. Drug therapy management: an empirical report of drug therapy problems, pharmacists' interventions, and results of pharmacists' actions. J Am Pharm Assoc. 2003;43:511-8.
27. Spalek VH, Gong WC. Pharmaceutical care in an integrated health system. J Am Pharm Assoc. 1999;39:553-7.
28. Mamdani MM, Racine E, McCreadie S, et al. Clinical and economic effectiveness of an inpatient anticoagulation service. Pharmacotherapy. 1999;19:1064-74.
29. Finley PR, Rens HR, Pont JT, et al. Impact of a collaborative pharmacy practice model on the treatment of depression in primary care. Am J Health Syst Pharm. 2002;59:1518-26.
30. Finley PR, Rens HR, Pont JT, et al. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy. 2003;23:1175-85.
31. Vivian EM. Improving blood pressure control in a pharmacist-managed hypertension clinic. Pharmacotherapy. 2002;22:1533-40.
32. Geletko SM, Poulakos MN. Pharmaceutical services in an HIV clinic. Am J Health Syst Pharm. 2002;59:709-13.
33. Crowson K, Collette D, Dang M, Rittase N. Transformation of a pharmacy department: impact on pharmacist interventions, error prevention, and cost. Jt Comm J Qual Improv. 2002;28:324-30.
34. McMullin ST, Hennenfent JA, Ritchie DJ, et al. A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions. Arch Intern Med. 1999;159:2306-9.
35. Bond CA, Raehl CL, Franke T. Clinical pharmacy services and hospital mortality rates. Pharmacotherapy. 1999;19:556-64.
36. Papadopoulos J, Rebuck JA, Lober C, et al. The critical care pharmacist: an essential intensive care practitioner. Pharmacotherapy. 2002;22:1484-8.
37. Triller DM, Hamilton RA, Briceland LL, et al. Home care pharmacy: extending clinical pharmacy services beyond infusion therapy. Am J Health Syst Pharm. 2000;57:1326-31.
38. Blakey SA, Hixson-Wallace JA. Clinical and economic effects of pharmacy services in geriatric ambulatory clinic. Pharmacotherapy. 2000;20:1198-203.
39. Smith DH, Fassett WE, Christensen DB. Washington State CARE project: downstream cost changes associated with the provision of cognitive services by pharmacists. J Am Pharm Assoc. 1999;39:650-7.
40. Lee M, Kemp JA, Canning A, et al. A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy. Arch Intern Med. 1999;159:2312-6.
41. Carter BL, Chrischilles EA, Scholz D, Hayase N, Bell N. Extent of services provided by pharmacists in the Iowa Medicaid Pharmaceutical Case Management program. J Am Pharm Assoc. 2003;43:24-33.
42. Sheth J, Parvatiyar A. Relationship marketing in consumer markets: antecedents and consequences. In: Sheth J, Parvatiyar A, eds. Handbook of relationship marketing. Thousand Oaks, Calif.: Sage Publications; 2000.
43. Vargo SL, Lusch RF. Evolving to a new dominant logic for marketing. J Market. 2004;68(Jan):1-17.
44. Johnson MD, Selnes F. Customer portfolio management: toward a dynamic theory of exchange relationships. J Market. 2004;68(Apr):1-17.
45. Palacioz K. Collaborative drug therapy management. Pharmacist's Letter. 2000;16:161001.
46. Bennett M, Jacobson-Wedret JE, eds. Building a successful collaborative pharmacy practice. Washington, D.C.: American Pharmacists Association; 2004.
47. Isetts BJ. Pharmaceutical care. In: Mueller B, ed, Pharmacotherapy self-assessment program-the science and practice of pharmacotherapy I, 4th ed., book 5. Kansas City, Mo.: American College of Clinical Pharmacy; 2002:147-82.
48. Rovers JP, Currie JD, Hagel HP, et al. A practical guide to pharmaceutical care. Washington D.C.: American Pharmacists Association; 1998.
49. Punekar Y, Lin SW, Thomas J 3rd. Progress of pharmacist collaborative practice: status of state laws and regulations and perceived impact of collaborative practice. J Am Pharm Assoc. 2003;43:503-10.
50. Dobson A, DaVanzo J, Koenig L, Book R. Medication therapy management services: a critical review. Final Report of The Lewin Group, Inc. Falls Church, Va.: The Lewin Group; 2005.